Abstract
Bioresorbable vascular scaffold (BVS) is a novel technology designed to overcome the
long-term limitations of permanent metallic stent implantation in percutaneous coronary
intervention. However, little is known about the development of coronary aneurysms
after the use of BVSs, and additional experience is needed to establish the entire
spectrum of complications related to the use of these emerging materials. We hereby
report an unusual case of early multiple coronary artery micro aneurysms formation
after BVS implantation.
Résumé
L’endoprothèse vasculaire biorésorbable (EVB) est une nouvelle technologie conçue
pour surmonter les limites à long terme de l’implantation d’une endoprothèse métallique
permanente par intervention coronarienne percutanée. Comme on en connaît peu sur le
développement des anévrismes coronariens après l’utilisation des EVB, une expérience
plus vaste est nécessaire pour établir le spectre entier des complications liées à
l’utilisation de ces matériaux émergents. Par la présente, nous rapportons un cas
inhabituel de formation précoce de multiples microanévrismes coronariens après l’implantation
d’une EVB.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Canadian Journal of CardiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Coronary artery aneurysms after drug-eluting stent implantation.JACC Cardiovasc Interv. 2008; 1: 14-21
- Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease.J Hum Genet. 2010; 55: 779-784
- Stent thrombosis with drug-eluting stents and bioresorbable scaffolds: evidence from a network meta-analysis of 147 trials.JACC Cardiovasc Interv. 2016; 9: 1203-1212
Article info
Publication history
Published online: September 13, 2016
Accepted:
September 8,
2016
Received:
August 13,
2016
Footnotes
See page 292.e11 for disclosure information.
Identification
Copyright
© 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
